NAPROGENIX INC
- LEXINGTON, KY 40506
- naprogenix.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $0
- Awards on record
- 0
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
NAPROGENIX INC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About NAPROGENIX INC
- Headquarters
- LEXINGTON, KY 40506
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIN1NBJ43SQGX7
- CAGE47N75
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
No federal prime awards on record
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 25 awards
- Total awarded
- $17,598,783
- By phase
- SBIR Phase I: 8
- SBIR Phase II: 7
- STTR Phase I: 6
- STTR Phase II: 4
- By agency
- Department of Health and Human Services: 25
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2021: 1
- 2020: 2
- 2018: 1
- 2017: 2
- 2016: 2
- 2014: 2
- 2013: 1
- 2012: 1
- 2010: 2
- 2008: 1
- 2007: 3
- 2006: 2
- 2004: 4
- 2003: 1
Awards (most recent first)
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2021 · $3,514,532
Sep 1, 2021 – Aug 31, 2025
Solicitation PA20-272 (2020) · Topic 150
Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2020 · $1,859,037
Sep 30, 2020 – Aug 31, 2023
Solicitation PA19-272 (2019) · Topic 999
Novel modulators of the dopamine transporter for alcohol and nicotine use disorders
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2020 · $2,972,532
Apr 5, 2020 – Mar 31, 2023
Solicitation PA19-272 (2019) · Topic 150
Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $231,474
Sep 1, 2018 – Aug 31, 2019
Solicitation PA17-302 (2017) · Topic NINDS
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $1,467,135
Aug 25, 2017 – Jul 31, 2022
Solicitation PAR15-154 (2015) · Topic 150
Harvesting specific plant metabolites from hairy root cultures using magnetized nanoparticles
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2017 · $1,029,017
Apr 1, 2017 – Mar 31, 2020
Solicitation PA16-302 (2016) · Topic R
Mutant transgenic plant cells as a novel source of drugs
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2016 · $1,050,389
Sep 22, 2016 – Aug 31, 2019
- Direct to Phase II
Solicitation PA18-591 (2016) · Topic 150
IGF OT IGF POTENTIAL COMMERCIALIZATION OF PROPRIETARY COMPOUND JR
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2016 · $285,767
Solicitation year 2016 · Topic NICHD
Harvesting specific plant metabolites from hairy root cultures using magnetized n
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $189,844
Solicitation PA13-235 (2014) · Topic NCCIH · Research partner: UNIVERSITY OF KENTUCKY
Novel flavonoids as anti-inflammatory agents in alcoholism
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $150,900
Solicitation PA11-096 (2014) · Topic NIAAA · Research partner: Stub
Selection-driven plant metabolites for treatment of CNS diseases
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2013 · $1,102,755
Sep 10, 2013 – Aug 31, 2016
Solicitation PA14-077 (2017) · Topic 150
NOVEL PHARMACOTHERAPIES FOR ALCOHOLISM, TOPIC #4409/24/2012 - 03/23/2013
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $149,697
Solicitation year 2012 · Topic NIAAA · Research partner: Stub
Selection-driven plant metabolites for treatment of CNS diseases
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2010 · $272,674
Solicitation PHS2010-2 (2010) · Topic NIAAA
Novel estrogen receptor ligands from plant genomics
STTR Phase II · Department of Health and Human Services (National Institutes of Health) · 2010 · $699,216
Solicitation PHS2010-2 (2010) · Topic NCCAM · Research partner: University Of Kentucky
Potential anti-relapse drugs: a plant genomics approach
STTR Phase II · Department of Health and Human Services (National Institutes of Health) · 2008 · $340,250
Solicitation PHS2009-2 (2009) · Research partner: UNIVERSITY OF KENTUCKY
Hypericum extracts as potential anti-relapse medications in alcoholism
STTR Phase II · Department of Health and Human Services (National Institutes of Health) · 2007 · $183,669
Solicitation year 2007
Hypericum extracts as potential anti-relapse medications in alcoholism
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $1,128,279
Research partner: UNIVERSITY OF KENTUCKY
Transgenic plant cells as a source of hepatoprotective drugs
STTR Phase II · Department of Health and Human Services (National Institutes of Health) · 2007 · $249,230
Solicitation year 2007 · Research partner: UNIVERSITY OF KENTUCKY
Novel estrogen receptor ligands from plant genomics
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2006 · $106,716
Research partner: UNIVERSITY OF KENTUCKY
Novel estrogen receptor ligands from plant genomics
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2006 · $106,716
Solicitation PHS2006-2 (2006)
Application of plant genomics to alcoholic brain damage
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2004 · $97,370
Solicitation PHS2004-2 (2004)
Application of plant genomics to alcoholic brain damage
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2004 · $97,370
Research partner: UNIVERSITY OF KENTUCKY
Potential anti-relapse drugs: a plant genomics approach
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2004 · $107,107
Research partner: UNIVERSITY OF KENTUCKY
Potential anti-relapse drugs: a plant genomics approach
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2004 · $107,107
Solicitation PHS2004-2 (2004)
Transgenic plant cells as source of hepatoprotective dr*
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2003 · $100,000
Research partner: UNIVERSITY OF KENTUCKY
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
No active exclusion on record (checked Nov 14, 2026).
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · as of Nov 14, 2026
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 14, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 14, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)PrimarySmall business under this code’s size standard
SAM.gov reports this entity as small under 1 of 1 NAICS code. Size is determined per code (SBA size standards).
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with NAPROGENIX INC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.